publication date: Apr. 14, 2017

In Brief

Ronald DeMatteo named chair of surgery at University of Pennsylvania

Ronald DeMatteo was appointed chair of the Department of Surgery in the Perelman School of Medicine at the University of Pennsylvania, effective July 1.

DeMatteo, a surgical oncologist, is an expert in treating liver, gallbladder and bile duct and pancreatic diseases, and abdominal sarcomas. He joins Penn, where he completed his surgical residency and postdoctoral fellowships, following 20 years at Memorial Sloan Kettering Cancer Center, where he most recently served as the vice chair of the department of Surgery and head of the division of general surgical oncology. He is also a professor of Surgery and an associate dean at Weill Medical College of Cornell University.

At Penn, DeMatteo will lead a department that includes 130 faculty across 11 divisions who provide advanced patient care, conduct a robust portfolio of basic science and clinical research, and run a preeminent surgical education program.

Over the course of his career, DeMatteo has served as the principal investigator on three national trials of the adjuvant drug imatinib following surgery to remove gastrointestinal stromal tumors, leading to an FDA approval and a new standard of care for the disease worldwide.

His clinical and laboratory research has resulted in a substantial body of scholarly work in high-impact journals including the Lancet, Lancet Oncology, Nature Medicine, and the Journal of Clinical Investigation. His research has been supported by more than $17 million in funding, including several grants from NIH and gifts from patients and philanthropic foundations.

DeMatteo earned his undergraduate degree in natural sciences from the Johns Hopkins University, and his medical degree from the Weill Medical College … Continue reading Ronald DeMatteo named chair of surgery at University of Pennsylvania

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.